Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

Delhi HC Cancels UNKIND Trademark, Upholds Mankind Pharmas KIND Family Rights

Delhi HC Grants Interim Relief to Mankind, Restrains AquaKind Labs from Using 'KIND' in Trademark

Farhat Nasim11 Nov 2024 6:51 PM IST

New Delhi: In relief to Mankind Pharma, the Delhi High Court has granted an ex-parte interim injunction restraining AquaKind Labs LLP from using the...

aristo pharma multivitamin tablets price

DoP Dismisses Aristo Pharma's Plea to Reassess Multivitamin Tablet Pricing Set by NPPA

Farhat Nasim10 Nov 2024 1:30 PM IST

New Delhi: The Department of Pharmaceuticals (DoP) recently rejected Aristo Pharmaceuticals' application challenging the price set for its...

Bristol Myers Squibb, SystImmune gets USFDA Breakthrough Therapy Designation for izalontamab brengitecan for previously treated Advanced EGFR Mutated Non Small Cell Lung Cancer

Delhi HC upholds Bristol Myers' patent for anti-cancer drug Dasatinib, imposes Rs 5L penalty on SP Labs

Farhat Nasim9 Nov 2024 5:40 PM IST

New Delhi: In relief to Bristol-Myers Squibb Holdings Ireland (BMS), the Delhi High Court has upheld its patent for the anti-cancer drug dasatinib and...

Dobustat price review plea rejected by dept of pharma

Dept of Pharma upholds NPPA Price Cap on Dobustat Injection

Farhat Nasim7 Nov 2024 3:45 PM IST

New Delhi: The Department of Pharmaceuticals (DoP) has upheld a decision by the National Pharmaceutical Pricing Authority (NPPA) regarding the price...

Investigation Lapses Lead to Acquittal in Hospital Voyeurism Case

Delhi Court slams Pharma company for copycat packaging, issues permanent injunction against its brand

Farhat Nasim6 Nov 2024 4:42 PM IST

"It appears that the defendant has kept the pack of the plaintiff in front while preparing its pack," the court said.

Viral video shows medical officer demanding Rs 500 from student in exchange for medical certificate, probe ordered

Assistant Drug Controller Caught taking Rs 40k bribe to approve pharmacy license, arrested

Farhat Nasim6 Nov 2024 4:39 PM IST

Bengaluru: In a recent case of corruption in Bengaluru, Lokayukta police has nabbed an assistant drug controller while he was accepting a bribe of Rs...

US Tariffs May Pressure Indian Pharma, Threaten Biocon Revenues: Fitch

DoP upholds NPPA ceiling price fixation for Azoran 50mg tablet

Farhat Nasim5 Nov 2024 6:10 PM IST

New Delhi: The Department of Pharmaceuticals (DoP) has upheld the ceiling price for Azathioprine 50mg tablets, as determined by the National...

Chemist Body up against Swiggy-PharmEasy's 10-Minute Medicine Delivery Model, Seeks DCGI Intervention

Farhat Nasim5 Nov 2024 4:04 PM IST

New Delhi: The All India Organization of Chemists and Druggists (AIOCD) has voiced strong objections to a potential partnership between Swiggy...

Revise Phase III Trial Protocol for Roflumilast Cream: CDSCO Panel Tells Sun Pharma

Sun Pharma alopecia drug Leqselvi launch blocked in US

Farhat Nasim4 Nov 2024 7:05 PM IST

New Delhi: Pharma giant, Sun Pharmaceutical's launch of its specialty drug Leqselvi in the U.S. market is in limbo as the U.S. District Court in...

AYUSH Simplifies Licensing for Drug Manufacturers with New Fee Structure, Details

Farhat Nasim4 Nov 2024 7:03 PM IST

New Delhi: The Ministry of AYUSH has amended the Drugs Rules of 1945 to streamline the licensing process for Ayurveda, Siddha, Sowa-Rigpa, Unani, and...

CDSCO Panel Accepts Glenmarks Apremilast Trial Report, Seeks 2-Year PSUR Data

DoP rejects Glenmark's appeal on price cap of Clotrimazole Cream

Farhat Nasim3 Nov 2024 12:45 PM IST

New Delhi: The Department of Pharmaceuticals has upheld the National Pharmaceutical Pricing Authority's (NPPA) decision on the price cap for...

Pfizer Wysolone DT price challenge denied: DoP upholds NPPA ceiling on Prednisolone Tablets

Farhat Nasim2 Nov 2024 1:00 PM IST

New Delhi: The Department of Pharmaceuticals (DoP) has upheld a price ceiling order issued by the National Pharmaceutical Pricing Authority (NPPA) on...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok